Advertisement
Skip to Content

Virtus KAR Health Sciences C RCGHX Fund Analysis

| Quantitative rating as of

Morningstar’s Analysis RCGHX

Will RCGHX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

The combination of an Average People Pillar rating and a Below Average Process Pillar rating limit Virtus KAR Health Sciences C to a Morningstar Quantitative Rating of Negative. Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Unlock our full analysis with Morningstar Investor